Sign Up to like & get
recommendations!
0
Published in 2019 at "Advances in Therapy"
DOI: 10.1007/s12325-019-00956-z
Abstract: IntroductionTo investigate the absolute bioavailability of esaxerenone and the effects of food on its pharmacokinetics (PK) after a single oral dose in healthy Japanese subjects.MethodsTwenty-four Japanese males aged 20–45 years were randomised to six groups (each…
read more here.
Keywords:
esaxerenone;
oral dose;
absolute bioavailability;
single oral ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Hypertension Research"
DOI: 10.1038/s41440-019-0211-0
Abstract: Although beneficial antihypertensive and antialbuminuric effects of steroidal mineralocorticoid receptor (MR) antagonists have been shown, the use of these drugs has been clinically limited in diabetic kidney disease (DKD) because of the high incidence of…
read more here.
Keywords:
esaxerenone;
diabetic mice;
injury;
blood pressure ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Hypertension Research"
DOI: 10.1038/s41440-020-00585-y
Abstract: Renin–angiotensin system inhibitors are recommended for treating hypertension with chronic kidney disease. The addition of a mineralocorticoid receptor blocker may be one option to achieve target blood pressure. We investigated the efficacy and safety of…
read more here.
Keywords:
esaxerenone;
kidney dysfunction;
patients moderate;
therapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "BMC Pharmacology & Toxicology"
DOI: 10.1186/s40360-020-00423-4
Abstract: Background To investigate the effects of coadministration of esaxerenone with amlodipine on the pharmacokinetics (PK) of each drug, and of esaxerenone on the PK of digoxin. Methods In three open-label, single-sequence, crossover studies, healthy Japanese…
read more here.
Keywords:
digoxin;
esaxerenone;
day days;
healthy japanese ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23168915
Abstract: Background: The nonsteroidal mineralocorticoid receptor blocker esaxerenone is effective in reducing blood pressure (BP). Objective: In this study, we investigated esaxerenone-driven sodium homeostasis and its association with changes in BP in Dahl salt-sensitive (DSS) hypertensive…
read more here.
Keywords:
sodium;
salt sensitive;
dahl salt;
treated rats ... See more keywords